0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Prescription Arthritis Medications Market Report & Forecast 2022-2028
Published Date: April 2022
|
Report Code: QYRE-Auto-39T10333
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global and United States Prescription Arthritis Medications Market Report Forecast 2022 2028

Global and United States Prescription Arthritis Medications Market Report & Forecast 2022-2028

Code: QYRE-Auto-39T10333
Report
April 2022
96 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.
Market Analysis and Insights: Global and United States Prescription Arthritis Medications Market
This report focuses on global and United States Prescription Arthritis Medications market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Prescription Arthritis Medications market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Prescription Arthritis Medications global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Prescription Arthritis Medications market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Prescription Arthritis Medications Scope and Market Size
Prescription Arthritis Medications market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Prescription Arthritis Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Prescription Arthritis Medications market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Oral
Topical

Segment by Application

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Abbott
Amgen
Boehringer Ingelheim
Horizon Pharma
Novartis
Pfizer
Regeneron
1 Study Coverage
1.1 Prescription Arthritis Medications Product Introduction
1.2 Global Prescription Arthritis Medications Outlook 2017 VS 2022 VS 2028
1.2.1 Global Prescription Arthritis Medications Sales in US$ Million for the Year 2017-2028
1.2.2 Global Prescription Arthritis Medications Sales in Volume for the Year 2017-2028
1.3 United States Prescription Arthritis Medications Outlook 2017 VS 2022 VS 2028
1.3.1 United States Prescription Arthritis Medications Sales in US$ Million for the Year 2017-2028
1.3.2 United States Prescription Arthritis Medications Sales in Volume for the Year 2017-2028
1.4 Prescription Arthritis Medications Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Prescription Arthritis Medications in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Prescription Arthritis Medications Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Prescription Arthritis Medications Market Dynamics
1.5.1 Prescription Arthritis Medications Industry Trends
1.5.2 Prescription Arthritis Medications Market Drivers
1.5.3 Prescription Arthritis Medications Market Challenges
1.5.4 Prescription Arthritis Medications Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Prescription Arthritis Medications Market Segment by Type
2.1.1 Oral
2.1.2 Topical
2.2 Global Prescription Arthritis Medications Market Size by Type
2.2.1 Global Prescription Arthritis Medications Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Prescription Arthritis Medications Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Prescription Arthritis Medications Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Prescription Arthritis Medications Market Size by Type
2.3.1 United States Prescription Arthritis Medications Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Prescription Arthritis Medications Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Prescription Arthritis Medications Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Prescription Arthritis Medications Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Online Pharmacies
3.1.3 Retail Pharmacies
3.2 Global Prescription Arthritis Medications Market Size by Application
3.2.1 Global Prescription Arthritis Medications Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Prescription Arthritis Medications Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Prescription Arthritis Medications Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Prescription Arthritis Medications Market Size by Application
3.3.1 United States Prescription Arthritis Medications Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Prescription Arthritis Medications Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Prescription Arthritis Medications Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Prescription Arthritis Medications Competitor Landscape by Company
4.1 Global Prescription Arthritis Medications Market Size by Company
4.1.1 Top Global Prescription Arthritis Medications Manufacturers Ranked by Revenue (2021)
4.1.2 Global Prescription Arthritis Medications Revenue by Manufacturer (2017-2022)
4.1.3 Global Prescription Arthritis Medications Sales by Manufacturer (2017-2022)
4.1.4 Global Prescription Arthritis Medications Price by Manufacturer (2017-2022)
4.2 Global Prescription Arthritis Medications Concentration Ratio (CR)
4.2.1 Prescription Arthritis Medications Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Prescription Arthritis Medications in 2021
4.2.3 Global Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Prescription Arthritis Medications Manufacturing Base Distribution, Product Type
4.3.1 Global Prescription Arthritis Medications Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Prescription Arthritis Medications Product Type
4.3.3 Date of International Manufacturers Enter into Prescription Arthritis Medications Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Prescription Arthritis Medications Market Size by Company
4.5.1 Top Prescription Arthritis Medications Players in United States, Ranked by Revenue (2021)
4.5.2 United States Prescription Arthritis Medications Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Prescription Arthritis Medications Sales by Players (2020, 2021 & 2022)
5 Global Prescription Arthritis Medications Market Size by Region
5.1 Global Prescription Arthritis Medications Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prescription Arthritis Medications Market Size in Volume by Region (2017-2028)
5.2.1 Global Prescription Arthritis Medications Sales in Volume by Region: 2017-2022
5.2.2 Global Prescription Arthritis Medications Sales in Volume Forecast by Region (2023-2028)
5.3 Global Prescription Arthritis Medications Market Size in Value by Region (2017-2028)
5.3.1 Global Prescription Arthritis Medications Sales in Value by Region: 2017-2022
5.3.2 Global Prescription Arthritis Medications Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prescription Arthritis Medications Market Size YoY Growth 2017-2028
6.1.2 North America Prescription Arthritis Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prescription Arthritis Medications Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prescription Arthritis Medications Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Prescription Arthritis Medications Market Size YoY Growth 2017-2028
6.3.2 Europe Prescription Arthritis Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prescription Arthritis Medications Market Size YoY Growth 2017-2028
6.4.2 Latin America Prescription Arthritis Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prescription Arthritis Medications Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Corporation Information
7.1.2 Abbott Description and Business Overview
7.1.3 Abbott Prescription Arthritis Medications Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Abbott Prescription Arthritis Medications Products Offered
7.1.5 Abbott Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Prescription Arthritis Medications Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Prescription Arthritis Medications Products Offered
7.2.5 Amgen Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporation Information
7.3.2 Boehringer Ingelheim Description and Business Overview
7.3.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim Prescription Arthritis Medications Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Horizon Pharma
7.4.1 Horizon Pharma Corporation Information
7.4.2 Horizon Pharma Description and Business Overview
7.4.3 Horizon Pharma Prescription Arthritis Medications Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Horizon Pharma Prescription Arthritis Medications Products Offered
7.4.5 Horizon Pharma Recent Development
7.5 Novartis
7.5.1 Novartis Corporation Information
7.5.2 Novartis Description and Business Overview
7.5.3 Novartis Prescription Arthritis Medications Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Novartis Prescription Arthritis Medications Products Offered
7.5.5 Novartis Recent Development
7.6 Pfizer
7.6.1 Pfizer Corporation Information
7.6.2 Pfizer Description and Business Overview
7.6.3 Pfizer Prescription Arthritis Medications Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Pfizer Prescription Arthritis Medications Products Offered
7.6.5 Pfizer Recent Development
7.7 Regeneron
7.7.1 Regeneron Corporation Information
7.7.2 Regeneron Description and Business Overview
7.7.3 Regeneron Prescription Arthritis Medications Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Regeneron Prescription Arthritis Medications Products Offered
7.7.5 Regeneron Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Prescription Arthritis Medications Industry Chain Analysis
8.2 Prescription Arthritis Medications Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Prescription Arthritis Medications Distributors
8.3 Prescription Arthritis Medications Production Mode & Process
8.4 Prescription Arthritis Medications Sales and Marketing
8.4.1 Prescription Arthritis Medications Sales Channels
8.4.2 Prescription Arthritis Medications Distributors
8.5 Prescription Arthritis Medications Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Prescription Arthritis Medications CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Prescription Arthritis Medications Market Trends
    Table 3. Prescription Arthritis Medications Market Drivers
    Table 4. Prescription Arthritis Medications Market Challenges
    Table 5. Prescription Arthritis Medications Market Restraints
    Table 6. Global Prescription Arthritis Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Prescription Arthritis Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Prescription Arthritis Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Prescription Arthritis Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Prescription Arthritis Medications Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Prescription Arthritis Medications Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Prescription Arthritis Medications Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Prescription Arthritis Medications Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Prescription Arthritis Medications Sales Share by Manufacturer, 2017-2022
    Table 15. Global Prescription Arthritis Medications Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Prescription Arthritis Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Prescription Arthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Arthritis Medications as of 2021)
    Table 18. Top Players of Prescription Arthritis Medications in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Prescription Arthritis Medications Product Type
    Table 20. Date of International Manufacturers Enter into Prescription Arthritis Medications Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Prescription Arthritis Medications Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Prescription Arthritis Medications Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Prescription Arthritis Medications Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Prescription Arthritis Medications Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Prescription Arthritis Medications Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Prescription Arthritis Medications Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Prescription Arthritis Medications Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Prescription Arthritis Medications Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Prescription Arthritis Medications Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Prescription Arthritis Medications Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Prescription Arthritis Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Prescription Arthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Prescription Arthritis Medications Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Prescription Arthritis Medications Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Prescription Arthritis Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Prescription Arthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Prescription Arthritis Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Prescription Arthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Prescription Arthritis Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Prescription Arthritis Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbott Corporation Information
    Table 43. Abbott Description and Business Overview
    Table 44. Abbott Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Abbott Prescription Arthritis Medications Product
    Table 46. Abbott Recent Development
    Table 47. Amgen Corporation Information
    Table 48. Amgen Description and Business Overview
    Table 49. Amgen Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Amgen Product
    Table 51. Amgen Recent Development
    Table 52. Boehringer Ingelheim Corporation Information
    Table 53. Boehringer Ingelheim Description and Business Overview
    Table 54. Boehringer Ingelheim Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Boehringer Ingelheim Product
    Table 56. Boehringer Ingelheim Recent Development
    Table 57. Horizon Pharma Corporation Information
    Table 58. Horizon Pharma Description and Business Overview
    Table 59. Horizon Pharma Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Horizon Pharma Product
    Table 61. Horizon Pharma Recent Development
    Table 62. Novartis Corporation Information
    Table 63. Novartis Description and Business Overview
    Table 64. Novartis Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Novartis Product
    Table 66. Novartis Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Regeneron Corporation Information
    Table 73. Regeneron Description and Business Overview
    Table 74. Regeneron Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Regeneron Product
    Table 76. Regeneron Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Prescription Arthritis Medications Customers List
    Table 80. Prescription Arthritis Medications Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prescription Arthritis Medications Product Picture
    Figure 2. Global Prescription Arthritis Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Prescription Arthritis Medications Market Size 2017-2028 (US$ Million)
    Figure 4. Global Prescription Arthritis Medications Sales 2017-2028 (K Units)
    Figure 5. United States Prescription Arthritis Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Prescription Arthritis Medications Market Size 2017-2028 (US$ Million)
    Figure 7. United States Prescription Arthritis Medications Sales 2017-2028 (K Units)
    Figure 8. United States Prescription Arthritis Medications Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Prescription Arthritis Medications Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Prescription Arthritis Medications Report Years Considered
    Figure 11. Product Picture of Oral
    Figure 12. Product Picture of Topical
    Figure 13. Global Prescription Arthritis Medications Market Share by Type in 2022 & 2028
    Figure 14. Global Prescription Arthritis Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Prescription Arthritis Medications Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Prescription Arthritis Medications Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Prescription Arthritis Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Prescription Arthritis Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Prescription Arthritis Medications Market Share by Type in 2022 & 2028
    Figure 20. United States Prescription Arthritis Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Prescription Arthritis Medications Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Prescription Arthritis Medications Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Prescription Arthritis Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Prescription Arthritis Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital Pharmacies
    Figure 26. Product Picture of Online Pharmacies
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Global Prescription Arthritis Medications Market Share by Application in 2022 & 2028
    Figure 29. Global Prescription Arthritis Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Prescription Arthritis Medications Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Prescription Arthritis Medications Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Prescription Arthritis Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Prescription Arthritis Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Prescription Arthritis Medications Market Share by Application in 2022 & 2028
    Figure 35. United States Prescription Arthritis Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Prescription Arthritis Medications Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Prescription Arthritis Medications Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Prescription Arthritis Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Prescription Arthritis Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Prescription Arthritis Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Prescription Arthritis Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Prescription Arthritis Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Prescription Arthritis Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Prescription Arthritis Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Prescription Arthritis Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Prescription Arthritis Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Prescription Arthritis Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Prescription Arthritis Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Prescription Arthritis Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Prescription Arthritis Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Prescription Arthritis Medications Value Chain
    Figure 74. Prescription Arthritis Medications Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global and United States Low dosage Hydrate Inhibitors Market Report Forecast 2022 2028
Global and United States Low dosage Hydrate Inhibitors Market Report & Forecast 2022-2028

Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition.Market Analysis and Insights Global and United States Low dosage Hydrate Inhibitors MarketThis report focuses on global and United States Low dosage Hydrate Inhibitors market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Low dosage Hydrate Inhibitors market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-8W10686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Drug Infusion Systems Market Report Forecast 2022 2028
Global and United States Drug Infusion Systems Market Report & Forecast 2022-2028

The drug infusion systems market includes various infusion systems products including the components such as pumps accessories and disposables.Market Analysis and Insights Global and United States Drug Infusion Systems MarketThis report focuses on global and United States Drug Infusion Systems market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Drug Infusion Systems market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-6M10719
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Insulin Drug Delivery Devices Market Report Forecast 2022 2028
Global and United States Insulin Drug Delivery Devices Market Report & Forecast 2022-2028

Insulin delivery devices that are currently available for the administration of insulin include syringes insulin infusion pumps jet injectors and pens.Market Analysis and Insights Global and United States Insulin Drug Delivery Devices MarketThis report focuses on global and United States Insulin Drug Delivery Devices market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Insulin Drug Delivery Devices market size is estimated to be worth US 14710 million in 2022 and is forecast to a readjusted size of US 19310 million by 2028 with a CAGR of 4.6 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-37X10341
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Stroke Treatment Drugs Market Report Forecast 2022 2028
Global and United States Stroke Treatment Drugs Market Report & Forecast 2022-2028

Stroke is a disruption in brain function caused by lack of blood flow to the brain.Market Analysis and Insights Global and United States Stroke Treatment Drugs MarketThis report focuses on global and United States Stroke Treatment Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Stroke Treatment Drugs market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-27B10301
Tue Jun 07 00:00:00 UTC 2022

Add to Cart